It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ultrasound stimulation is a type of mechanical stress, and low-intensity pulsed ultrasound (LIPUS) devices have been used clinically to promote fracture healing. However, it remains unclear which skeletal cells, in particular osteocytes or osteoblasts, primarily respond to LIPUS stimulation and how they contribute to fracture healing. To examine this, we utilized medaka, whose bone lacks osteocytes, and zebrafish, whose bone has osteocytes, as in vivo models. Fracture healing was accelerated by ultrasound stimulation in zebrafish, but not in medaka. To examine the molecular events induced by LIPUS stimulation in osteocytes, we performed RNA sequencing of a murine osteocytic cell line exposed to LIPUS. 179 genes reacted to LIPUS stimulation, and functional cluster analysis identified among them several molecular signatures related to immunity, secretion, and transcription. Notably, most of the isolated transcription-related genes were also modulated by LIPUS in vivo in zebrafish. However, expression levels of early growth response protein 1 and 2 (Egr1, 2), JunB, forkhead box Q1 (FoxQ1), and nuclear factor of activated T cells c1 (NFATc1) were not altered by LIPUS in medaka, suggesting that these genes are key transcriptional regulators of LIPUS-dependent fracture healing via osteocytes. We therefore show that bone-embedded osteocytes are necessary for LIPUS-induced promotion of fracture healing via transcriptional control of target genes, which presumably activates neighboring cells involved in fracture healing processes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hokkaido University, Oral Biochemistry and Molecular Biology, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691); Hokkaido University, Oral Diagnosis and Medicine, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
2 Hokkaido University, Oral Biochemistry and Molecular Biology, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691); Hokkaido University, Dental Anesthesiology, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
3 Hokkaido University, Oral Biochemistry and Molecular Biology, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
4 Hokkaido University, Oral Diagnosis and Medicine, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
5 Hokkaido University, Dental Anesthesiology, Graduate School of Dental Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)